Ribosomal protein S27 pseudogene 2 (RPS27P2)

Ribosomal protein S27 pseudogene 2 (RPS27P2) is classified as a *pseudogene*, meaning it is a genomic DNA sequence related to the functional RPS27 gene, but it is not known to encode a functional protein product in human cells[3][1]. Pseudogenes like RPS27P2 do not function as active targets for therapeutic molecules, drug development, or serve as typical disease-associated proteins, receptors, or enzymes[3][4]. There is no evidence currently suggesting RPS27P2 has a biological function, role in disease, or interaction with known drugs. \nPseudogenes in this family, including RPS27P2, are often annotated for comparative genomics and gene evolution studies and may sometimes be transcribed, but there is no evidence at present that RPS27P2 itself produces a functional protein or exerts any direct biological effect in humans[3][1].\n\nSupporting context: \n- RPS27P2 is specifically listed in gene/protein databases as a pseudogene, with no reported protein product or functional data[3][1].\n- It is distinct from the functional ribosomal protein S27 gene (RPS27), which is an actual ribosomal protein and is involved in processes like protein synthesis and, in some isoforms, regulation of the p53 pathway[5]. \n- There are multiple ribosomal protein S27 pseudogenes in the human genome, but most, including RPS27P2, lack experimental evidence for protein-coding function[3][6]. \n\nClarification: \n- Pseudogenes are not considered drug targets, and the entry is “incorrect” as a therapeutic target listing[3][1].\n- No links to disease, biomarkers, drugs, or mechanism of action are established for RPS27P2.\n\nIf you require data on the functional ribosomal protein S27 (RPS27, not RPS27P2), which does have distinct biological and disease roles[5], please specify.

Other names

HsT16324RPS27P2